Fernanda Herrera

2.6k total citations · 1 hit paper
65 papers, 1.6k citations indexed

About

Fernanda Herrera is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Obstetrics and Gynecology. According to data from OpenAlex, Fernanda Herrera has authored 65 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pulmonary and Respiratory Medicine, 17 papers in Oncology and 16 papers in Obstetrics and Gynecology. Recurrent topics in Fernanda Herrera's work include Advanced Radiotherapy Techniques (15 papers), Endometrial and Cervical Cancer Treatments (15 papers) and Cancer Immunotherapy and Biomarkers (13 papers). Fernanda Herrera is often cited by papers focused on Advanced Radiotherapy Techniques (15 papers), Endometrial and Cervical Cancer Treatments (15 papers) and Cancer Immunotherapy and Biomarkers (13 papers). Fernanda Herrera collaborates with scholars based in Switzerland, Netherlands and Spain. Fernanda Herrera's co-authors include George Coukos, Jean Bourhis, John O. Prior, Melita Irving, Lana E. Kandalaft, Mahmut Özsahin, Andrés F. Cardona, Deepti R. Nagarkar, Marleen Kok and Myriam Chalabi and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Fernanda Herrera

57 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Radiotherapy combination opportunities leveraging immunity for the next oncology practice

2016 402 citations Fernanda Herrera, Jean Bourhis et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fernanda Herrera Switzerland	19	625	590	283	257	257	65	1.6k
Gregory N. Gan United States	20	807 1.3×	954 1.6×	168 0.6×	239 0.9×	77 0.3×	60	1.8k
Gail Walker United States	18	323 0.5×	741 1.3×	129 0.5×	264 1.0×	154 0.6×	50	1.7k
Sophie Espenel France	16	300 0.5×	201 0.3×	110 0.4×	59 0.2×	68 0.3×	90	864
Philip Wong Canada	20	433 0.7×	360 0.6×	174 0.6×	98 0.4×	71 0.3×	71	1.4k
San‐Gang Wu China	24	803 1.3×	545 0.9×	162 0.6×	23 0.1×	58 0.2×	156	2.0k
Li Ma China	22	297 0.5×	517 0.9×	420 1.5×	59 0.2×	35 0.1×	99	1.3k
Tatsuo Nakagawa Japan	21	408 0.7×	594 1.0×	184 0.7×	31 0.1×	127 0.5×	92	1.5k
Paul B. Romesser United States	25	958 1.5×	865 1.5×	397 1.4×	342 1.3×	342 1.3×	112	2.7k
Hayeon Kim United States	23	184 0.3×	222 0.4×	176 0.6×	318 1.2×	28 0.1×	104	1.6k

Countries citing papers authored by Fernanda Herrera

Since Specialization

Citations

This map shows the geographic impact of Fernanda Herrera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fernanda Herrera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fernanda Herrera more than expected).

Fields of papers citing papers by Fernanda Herrera

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fernanda Herrera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fernanda Herrera. The network helps show where Fernanda Herrera may publish in the future.

Co-authorship network of co-authors of Fernanda Herrera

This figure shows the co-authorship network connecting the top 25 collaborators of Fernanda Herrera. A scholar is included among the top collaborators of Fernanda Herrera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fernanda Herrera. Fernanda Herrera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zeverino, Michele, et al.. (2025). An automated patient‐specific segment reduction‐based beam angle optimization technique for deep learning auto‐planning for early breast cancer. Journal of Applied Clinical Medical Physics. 26(10). e70293–e70293.

Geyer, R., Till T. Böhlen, Raphaël Moeckli, et al.. (2025). Decrease in dose per fraction impairs the FLASH sparing effect in murine intestine model. Radiotherapy and Oncology. 214. 111262–111262.

Kinj, Rémy, Luis Schiappacasse, Wendy Jeanneret‐Sozzi, et al.. (2025). Machine stability and dosimetry for ultra‐high dose rate FLASH radiotherapy human clinical protocol. Journal of Applied Clinical Medical Physics. 26(6). e70102–e70102. 4 indexed citations

Banerjee, Susana, Anita Wolfer, Petronella B. Ottevanger, et al.. (2025). Bevacizumab, Atezolizumab, and Acetylsalicylic Acid in Recurrent, Platinum-Resistant Ovarian Cancer: The EORTC 1508-GCG Phase II Study. Clinical Cancer Research. 31(11). 2145–2153. 3 indexed citations

Herrera, Fernanda, et al.. (2025). Can Induction Chemotherapy Prior To Definitive Chemoradiation Impair Chemotherapy And Immunotherapy Treatment Effect In Persistent, Inoperable, Cervical Cancer?. International Journal of Gynecological Cancer. 35(2). 100524–100524.

Grilj, Veljko, J. F. Pernot, Till T. Böhlen, et al.. (2025). Average Dose Rate is the Major Temporal Beam Structure Parameter for Preserving Murine Intestines With Pulsed Electron FLASH Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 123(2). 593–601. 6 indexed citations

Boughdad, Sarah, Niklaus Schaefer, John O. Prior, et al.. (2024). Spatial Distribution of Recurrence and Long-Term Toxicity Following Dose Escalation to the Dominant Intra-Prostatic Nodule for Intermediate–High-Risk Prostate Cancer: Insights from a Phase I/II Study. Cancers. 16(11). 2097–2097. 2 indexed citations

Yarza, Ramón, Melpomeni Kountouri, Corneel Coens, et al.. (2024). Progression-free survival as a potential surrogate end point for overall survival in advanced cervical carcinoma. International Journal of Gynecological Cancer. 35(2). 100012–100012. 2 indexed citations

Böhlen, Till T., Jean‐François Germond, Kristoffer Petersson, et al.. (2023). Effect of Conventional and Ultrahigh Dose Rate FLASH Irradiations on Preclinical Tumor Models: A Systematic Analysis. International Journal of Radiation Oncology*Biology*Physics. 117(4). 1007–1017. 24 indexed citations

10.

Latifyan, Sofiya, et al.. (2022). 2022-RA-1349-ESGO Treated as a skin carcinoma: recurrent, metastatic squamous cell carcinoma from a degenerated mature teratoma of the ovary. International Journal of Gynecological Cancer. 32. A327–A328.

11.

Gaide, Olivier, Fernanda Herrera, Wendy Jeanneret Sozzi, et al.. (2022). Comparison of ultra-high versus conventional dose rate radiotherapy in a patient with cutaneous lymphoma. Radiotherapy and Oncology. 174. 87–91. 59 indexed citations

12.

Herrera, Fernanda, et al.. (2021). A Locally Advanced Endometrioid Adenocarcinoma Arising from Vaginal Endometriosis: Management and Review of the Literature. SHILAP Revista de lepidopterología. 4(3). 29–29.

13.

Moeckli, Raphaël, et al.. (2021). A new method to visualize and to spare the ureters during SBRT for oligo metastatic patients. Technical Innovations & Patient Support in Radiation Oncology. 19. 7–10. 2 indexed citations

14.

Chalabi, Myriam, Andrés F. Cardona, Deepti R. Nagarkar, et al.. (2020). Efficacy of chemotherapy and atezolizumab in patients with non-small-cell lung cancer receiving antibiotics and proton pump inhibitors: pooled post hoc analyses of the OAK and POPLAR trials. Annals of Oncology. 31(4). 525–531. 201 indexed citations

15.

Zeverino, Michele, André Durham, R. Jumeau, et al.. (2019). Novel inverse planning optimization algorithm for robotic radiosurgery: First clinical implementation and dosimetric evaluation. Physica Medica. 64. 230–237. 24 indexed citations

16.

Scher, Nathaniel, J. Castelli, Adrien Depeursinge, et al.. (2018). (18F)-FDG PET/CT parameters to predict survival and recurrence in patients with locally advanced cervical cancer treated with chemoradiotherapy. Cancer/Radiothérapie. 22(3). 229–235. 18 indexed citations

17.

Herrera, Fernanda, et al.. (2014). Long-term Outcome and Late Side Effects in Endometrial Cancer Patients Treated with Surgery and Postoperative Radiation Therapy. Annals of Surgical Oncology. 21(7). 2390–2397. 6 indexed citations

18.

Pracht, Marc, Fernanda Herrera, Thomas Tawadros, & Dominik Berthold. (2013). [Immunotherapy: a therapeutic revolution against prostate cancer?].. PubMed. 9(387). 1070–5. 2 indexed citations

19.

Herrera, Fernanda & John O. Prior. (2013). The role of PET/CT in cervical cancer. Frontiers in Oncology. 3. 34–34. 62 indexed citations

20.

Berthold, Dominik, et al.. (2011). Secondary Cancer Risk for Stage I Seminoma Patients - a Comparison of Adjuvant Treatment Versus Surveillance. IRIS. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact